PPARγ ligand production is tightly linked to clonal expansion during initiation of adipocyte differentiation

Journal of Lipid Research

Volumn 55, Issue 12, 2014, Pages 2491-2500

  Hallenborg, Philip ^a   Petersen, Rasmus Koefoed ^b   Feddersen, Soren ^a,d   Sundekilde, Ulrik ^a,e   Hansen, Jacob B ^b   Blagoev, Blagoy ^a   Madsen, Lise ^b,c   Kristiansen, Karsten ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c National Institute of   (Norway)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

Adipocytes; Arachidonic acid; Cell cycling; Nuclear receptors lipid ligands; Peroxisome proliferator activated receptor; Transcription

Indexed keywords

ARACHIDONIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; GAL4 PROTEIN, S CEREVISIAE; LIGAND; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; EMBRYO; FIBROBLAST; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; 3T3 CELL LINE; AGONISTS; ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KINETICS; KNOCKOUT MOUSE; METABOLISM; MITOSIS; PROTEIN DOMAIN; WHITE ADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOGENESIS; ANIMALS; ARACHIDONIC ACID; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KINETICS; LIGANDS; MICE; MICE, KNOCKOUT; MITOSIS; PEPTIDE FRAGMENTS; PPAR GAMMA; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84919723507     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M050658     Document Type: Article

References (51)

1. Lefterova, M. I., A. K. Haakonsson, M. A. Lazar, and S. Mandrup. 2014. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol. Metab. 25: 293-302.
2. Rosen, E. D., and B. M. Spiegelman. 2014. What we talk about when we talk about fat. Cell. 156: 20-44.
3. Castillo, G., R. P. Brun, J. K. Rosenfield, S. Hauser, C. W. Park, A. E. Troy, M. E. Wright, and B. M. Spiegelman. 1999. An adipogenic cofactor bound by the differentiation domain of PPARgamma. EMBO J. 18: 3676-3687.
4. Oberfield, J. L., J. L. Collins, C. P. Holmes, D. M. Goreham, J. P. Cooper, J. E. Cobb, J. M. Lenhard, E. A. Hull-Ryde, C. P. Mohr, S. G. Blanchard, et al. 1999. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc. Natl. Acad. Sci. USA. 96: 6102-6106.
5. Camp, H. S., A. Chaudhry, and T. Leff. 2001. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Endocrinology. 142: 3207-3213.
6. Tzameli, I., H. Fang, M. Ollero, H. Shi, J. K. Hamm, P. Kievit, A. N. Hollenberg, and J. S. Flier. 2004. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 279: 36093-36102.
7. Walkey, C. J., and B. M. Spiegelman. 2008. A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis. J. Biol. Chem. 283: 24290-24294.
8. Madsen, L., R. K. Petersen, M. B. Sorensen, C. Jorgensen, P. Hallenborg, L. Pridal, J. Fleckner, E. Z. Amri, P. Krieg, G. Furstenberger, et al. 2003. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem. J. 375: 539-549.
9. Tang, Q. Q., T. C. Otto, and M. D. Lane. 2003. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA. 100: 44-49.
10. Cho, Y. C., and C. R. Jefcoate. 2004. PPARgamma1 synthesis and adipogenesis in C3H10T1/2 cells depends on S-phase progression, but does not require mitotic clonal expansion. J. Cell. Biochem. 91: 336-353.
11. Tang, Q. Q., M. Gronborg, H. Huang, J. W. Kim, T. C. Otto, A. Pandey, and M. D. Lane. 2005. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc. Natl. Acad. Sci. USA. 102: 9766-9771.
12. Park, B. H., L. Qiang, and S. R. Farmer. 2004. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fi broblasts into adipocytes. Mol. Cell. Biol. 24: 8671-8680.
13. Salma, N., H. Xiao, and A. N. Imbalzano. 2006. Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. J. Mol. Endocrinol. 36: 139-151.
14. Naaz, A., D. R. Holsberger, G. A. Iwamoto, A. Nelson, H. Kiyokawa, and P. S. Cooke. 2004. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J. 18: 1925-1927.
15. Inoue, N., N. Yahagi, T. Yamamoto, M. Ishikawa, K. Watanabe, T. Matsuzaka, Y. Nakagawa, Y. Takeuchi, K. Kobayashi, A. Takahashi, et al. 2008. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J. Biol. Chem. 283: 21220-21229.
16. Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
17. Petersen, R. K., L. Madsen, L. M. Pedersen, P. Hallenborg, H. Hagland, K. Viste, S. O. Doskeland, and K. Kristiansen. 2008. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol. Cell. Biol. 28: 3804-3816.
18. Hansen, J. B., R. K. Petersen, B. M. Larsen, J. Bartkova, J. Alsner, and K. Kristiansen. 1999. Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retino-blastoma protein in adipocyte differentiation. J. Biol. Chem. 274: 2386-2393.
19. Hansen, J. B., H. Zhang, T. H. Rasmussen, R. K. Petersen, E. N. Flindt, and K. Kristiansen. 2001. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J. Biol. Chem. 276: 3175-3182.
20. Ventura, A., A. Meissner, C. P. Dillon, M. McManus, P. A. Sharp, L. Van Parijs, R. Jaenisch, and T. Jacks. 2004. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA. 101: 10380-10385.
21. Okada, S., M. Mori, and J. E. Pessin. 2003. Introduction of DNA into 3T3-L1 adipocytes by electroporation. Methods Mol. Med. 83: 93-96.
22. Berberich, S. J., V. Litteral, L. D. Mayo, D. Tabesh, and D. Morris. 1999. mdm-2 gene amplification in 3T3-L1 preadipocytes. Differentiation. 64: 205-212.
23. Molchadsky, A., O. Ezra, P. G. Amendola, D. Krantz, I. Kogan-Sakin, Y. Buganim, N. Rivlin, N. Goldfinger, V. Folgiero, R. Falcioni, et al. 2013. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death Differ. 20: 774-783.
24. Molchadsky, A., I. Shats, N. Goldfinger, M. Pevsner-Fischer, M. Olson, A. Rinon, E. Tzahor, G. Lozano, D. Zipori, R. Sarig, et al. 2008. p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS ONE. 3: e3707.
25. Prives, C. 1994. How loops, beta sheets, and alpha helices help us to understand p53. Cell. 78: 543-546.
26. Gu, B., and W. G. Zhu. 2012. Surf the post-translational modification network of p53 regulation. Int. J. Biol. Sci. 8: 672-684.
27. Bruins, W., O. Bruning, M. J. Jonker, E. Zwart, T. V. van der Hoeven, J. L. Pennings, H. Rauwerda, A. de Vries, and T. M. Breit. 2008. The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts. Mol. Cell. Biol. 28: 1974-1987.
28. Bruins, W., M. J. Jonker, O. Bruning, J. L. Pennings, M. M. Schaap, E. M. Hoogervorst, H. van Steeg, T. M. Breit, and A. de Vries. 2007. Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation. Carcinogenesis. 28: 1814-1823.
29. Harris, S. L., and A. J. Levine. 2005. The p53 pathway: positive and negative feedback loops. Oncogene. 24: 2899-2908.
30. Tomlinson, J. J., A. Boudreau, D. Wu, E. Atlas, and R. J. Hache. 2006. Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology. 147: 5284-5293.
31. Jefcoate, C. R., S. Wang, and X. Liu. 2008. Methods that resolve different contributions of clonal expansion to adipogenesis in 3T3-L1 and C3H10T1/2 cells. Methods Mol. Biol. 456: 173-193.
32. Tang, Q. Q., T. C. Otto, and M. D. Lane. 2004. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. USA. 101: 9607-9611.
33. Tseng, Y. H., E. Kokkotou, T. J. Schulz, T. L. Huang, J. N. Winnay, C. M. Taniguchi, T. T. Tran, R. Suzuki, D. O. Espinoza, Y. Yamamoto, et al. 2008. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 454: 1000-1004.
34. Asahina, I., T. K. Sampath, and P. V. Hauschka. 1996. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp. Cell Res. 222: 38-47.
35. Hallenborg, P., C. Jorgensen, R. K. Petersen, S. Feddersen, P. Araujo, P. Markt, T. Langer, G. Furstenberger, P. Krieg, A. Koppen, et al. 2010. Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity. Mol. Cell. Biol. 30: 4077-4091.
36. Cheung, K. J., I. Tzameli, P. Pissios, I. Rovira, O. Gavrilova, T. Ohtsubo, Z. Chen, T. Finkel, J. S. Flier, and J. M. Friedman. 2007. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab. 5: 115-128.
37. Schupp, M., and M. A. Lazar. 2010. Endogenous ligands for nuclear receptors: digging deeper. J. Biol. Chem. 285: 40409-40415.
38. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83: 803-812.
39. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83: 813-819.
40. Bell-Parikh, L. C., T. Ide, J. A. Lawson, P. McNamara, M. Reilly, and G. A. FitzGerald. 2003. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J. Clin. Invest. 112: 945-955.
41. Hamm, J. K., B. H. Park, and S. R. Farmer. 2001. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 276: 18464-18471.
42. Yu, Z., C. Schneider, W. E. Boeglin, and A. R. Brash. 2006. Human and mouse eLOX3 have distinct substrate specifi cities: implications for their linkage with lipoxygenases in skin. Arch. Biochem. Biophys. 455: 188-196.
43. Yu, Z., C. Schneider, W. E. Boeglin, L. J. Marnett, and A. R. Brash. 2003. The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc. Natl. Acad. Sci. USA. 100: 9162-9167.
44. van Rossum, G. S., A. S. Vlug, H. van den Bosch, A. J. Verkleij, and J. Boonstra. 2001. Cytosolic phospholipase A(2) activity during the ongoing cell cycle. J. Cell. Physiol. 188: 321-328.
45. Boonstra, J., and G. S. van Rossum. 2003. The role of cytosolic phospholipase A2 in cell cycle progression. Prog. Cell Cycle Res. 5: 181-190.
46. Prusty, D., B. H. Park, K. E. Davis, and S. R. Farmer. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 277: 46226-46232.
47. Schopfer, F. J., Y. Lin, P. R. Baker, T. Cui, M. Garcia-Barrio, J. Zhang, K. Chen, Y. E. Chen, and B. A. Freeman. 2005. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. USA. 102: 2340-2345.
48. Sertznig, P., M. Seifert, W. Tilgen, and J. Reichrath. 2007. Present concepts and future outlook: function of peroxisome proliferatoractivated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. J. Cell. Physiol. 212: 1-12.
49. Kim, H. J., I. S. Woo, E. S. Kang, S. Y. Eun, H. J. Kim, J. H. Lee, K. C. Chang, J. H. Kim, and H. G. Seo. 2006. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity. Biochem. Biophys. Res. Commun. 347: 698-706.
50. Sabatino, L., A. Casamassimi, G. Peluso, M. V. Barone, D. Capaccio, C. Migliore, P. Bonelli, A. Pedicini, A. Febbraro, A. Ciccodicola, et al. 2005. A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing. J. Biol. Chem. 280: 26517-26525.
51. Sarraf, P., E. Mueller, W. M. Smith, H. M. Wright, J. B. Kum, L. A. Aaltonen, A. de la Chapelle, B. M. Spiegelman, and C. Eng. 1999. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol. Cell. 3: 799-804.